NEW YORK, Jan. 20 (GenomeWeb News) - Mergen and Oxford Gene Technology agreed on Jan. 13 to settle the patent-infringement litigation between them, according to Mergen spokesperson Jamie Love.
Under the terms of the deal, Sunnyvale, Calif.-based Mergen has purchased a license from Oxford, UK-based OGT allowing the company to manufacture and sell microarrays for investigating gene expression. Mergen has also dropped a countersuit as part of the deal.
Mergen spokesperson Love declined to disclose financial terms of the agreement.
Mergen sells the ExpressChip microarray.
The suit was one of several that OGT filed in the US District Court for the Northern District of Illinois in December 2002 to protect its broad US patent covering oligonucleotide arrays, according to GenomeWeb News' sister publication BioArray News.
Oxford Gene Technology manages the IP of microarray pioneer Edwin Southern, who jointly owns the patents with
In mid-June, the company settled a similar suit it had filed in the same court, at the same time, against Motorola. That suit concerned Motorola's eSensor DNA Detection System.